Composition
Susp 40 mg: Per 5 ml: Cefpodoxime 40 mg (as cefpodoxime proxetil); granules for susp. Susp 100 mg: Per 5 ml: Cefpodoxime 100 mg (as cefpo-doximeproxetil); granules for susp. Cap/Tab 100 mg/20
Indications & Dosage
Lower Respiratory Infection: Adults & Children 12 yrs: 200 mg every 12 hr for 10-14 days. Children 2 months-11 yrs: 5 mg/kg every 12 hr for 10-14 days. Otitis Media: Adults & Children 12 yr: 200 mg every 12 hr for 5 days; Children 2 months-11 yr: 5 mg/kg every 12 hr for 5 days. Upper Respiratory Infection, Pharyngitis, Tonsillitis: Adults & Children 12 yrs: 100 mg every 12 hr for 5-10 days. Children 2 months-11 yrs: 5 mg/kg every 12 hr for 5-10 days. Sinusitis: Adults & Children: 12 yr: 200 mg every 12 hr for 10 days; Children 2 months-11 yr: 5 mg/kg every 12 hr for 10 days. Skin Infection: Adults & Children: 12 yr: 400 mg every 12 hr for 7-14 days. Urinary Tract Infection: Adults & Children: 12 yr: 100 mg every 12 hr for 7 days.
Contraindications
Phenylketonuria (susp only; contains aspartame).
Precautions
Beta-lactam and hypersensitivity, hepatic and renal impairment
Interactions
Antacids, furosemide, aminoglycosides.H2-antagonists, probenecid
Pregnancy
No evidence of harm
Lactation
Caution advised
Side Effects
Abdominal discomfort, agranulocytosis,allergic reactions,anaphylaxis, aplastic anaemia, blood disorders, confusion, disturbances in liver enzymes, dizziness, eosinophilia, haemolytic anaemia, hallucinations, headache, hypertonia, leucopenia, nervousness, pruritus, rashes, fever and arthralgia, sleep disturbances, urticaria, GI disturbances, Rare: Stevens-Johnsonsyndrome, thrombocytopenia, toxic epidermal necrolysis, transient cholestatic jaundice, transient hepatitis